| A comprehensive subcellular atlas of the Toxoplasma proteome via hyperLOPIT provides spatial context for protein functions K Barylyuk, L Koreny, H Ke, S Butterworth, OM Crook, I Lassadi, V Gupta, ... Cell host & microbe 28 (5), 752-766. e9, 2020 | 270* | 2020 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 249 | 2020 |
| A CRISPR platform for targeted in vivo screens identifies Toxoplasma gondii virulence factors in mice J Young, C Dominicus, J Wagener, S Butterworth, X Ye, G Kelly, M Ordan, ... Nature Communications 10 (1), 3963, 2019 | 77 | 2019 |
| Scalable and robust SARS-CoV-2 testing in an academic center J Aitken, K Ambrose, S Barrell, R Beale, G Bineva-Todd, D Biswas, ... Nature biotechnology 38 (8), 927-931, 2020 | 39 | 2020 |
| Stable endocytic structures navigate the complex pellicle of apicomplexan parasites L Koreny, BN Mercado-Saavedra, CM Klinger, K Barylyuk, S Butterworth, ... Nature communications 14 (1), 2167, 2023 | 31* | 2023 |
| Toxoplasma gondii virulence factor ROP1 reduces parasite susceptibility to murine and human innate immune restriction S Butterworth, F Torelli, EJ Lockyer, J Wagener, OR Song, M Broncel, ... PLoS Pathogens 18 (12), e1011021, 2022 | 30* | 2022 |
| A heterotrimeric complex of Toxoplasma proteins promotes parasite survival in interferon gamma-stimulated human cells EJ Lockyer, F Torelli, S Butterworth, OR Song, S Howell, A Weston, P East, ... PLoS Biology 21 (7), e3002202, 2023 | 19 | 2023 |
| Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy S Balestrini, MJ Koepp, S Gandhi, HM Rickman, GY Shin, CF Houlihan, ... Epilepsy & Behavior 115, 107602, 2021 | 16 | 2021 |
| High-throughput identification of Toxoplasma gondii effector proteins that target host cell transcription S Butterworth, K Kordova, S Chandrasekaran, KK Thomas, F Torelli, ... Cell Host & Microbe 31 (10), 1748-1762. e8, 2023 | 10* | 2023 |
| Paracrine rescue of MYR1-deficient Toxoplasma gondii mutants reveals limitations of pooled in vivo CRISPR screens F Torelli, DM da Fonseca, S Butterworth, JC Young, M Treeck bioRxiv, 2024.08. 23.609334, 2024 | | 2024 |
| In vivo CRISPR screens identify GRA12 as a transcendent secreted virulence factor across Toxoplasma gondii strains and mouse subspecies F Torelli, SW Butterworth, EJ Lockyer, OR Song, J Pearson-Farr, M Treeck bioRxiv, 2024.09. 10.611481, 2024 | | 2024 |
